Clinical trials on Ayurvedic drugs
Reverse pharmacology is one of the approaches to clinical trials on Ayurvedic drugs.
The U.S. National Institutes of Health states that
"Most clinical trials of Ayurvedic approaches have been small, had problems with research designs, or lacked appropriate control groups, potentially affecting research results."
The Indian Council of Medical Research has issued guidance on conducting trials of ayurvedic substances. It says the substances must adhere to the recipes traditionally used and care must be taken to ensure there is no contamination of plant ingredients (e.g., by herbicides).
Draft of the guidelines
The government of India has come up with a draft of the guidelines.
Some Ayurvedic experts and mainly Ayurvedic drug manufacturers believe that this method is not practical and should not applied to Ayurvedic drugs, as it would involve a huge amount of cost. There are other problems associated with clinical trials of Ayurvedic medicines
- Department of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy
- clinical Trials
- Rasa shastra
- "Ayurvedic medicine". Cancer Research UK. Retrieved August 2013.
- "Ethical guidelines for biomedical research on human participants" (pdf). Indian Council of Medical Research. 2006. Retrieved 19 October 2013.